F&O Strategy: Go long on Sun Pharma

K. S. Badri Narayanan | Updated on: Jun 11, 2022

Option trading indicates the stock may move between ₹800 and ₹900

Shares of Sun Pharmaceutical Industries (₹845.7) are ruling at a crucial level. The stock finds an immediate resistance at ₹865 and the major one at ₹901. A close above the latter will trigger a fresh rally in the stock. It finds an immediate support at ₹825 and the next one at ₹799. A close below the latter will alter the long-term positive outlook on Sun Pharma. We expect the stock to sustain the bullish trend with short-term volatility.

F&O pointers: The counter saw unwinding of open positions in the last few days as the futures slipped from ₹890 to ₹846. From 2.21 crore shares on May 31, open interests dipped to 2.11 crore shares. Option trading indicates the stock may move between ₹800 and ₹900.

Strategy: We advise traders to buy 850-call on Sun Pharma. As the option closed with a premium of ₹20.65, this will cost the traders ₹14,455, which will be the maximum loss in this strategy. This will happen if Sun Pharma stays at or below ₹850 on expiry. We expect the stock to fall initially but bounce back later. If the stock slips sharply, traders can buy the 840-call instead.

We advise traders to exit the position with profit of ₹15,000 or if the loss mounts to ₹9,800. Alternatively, traders could consider going long on Sun Pharma futures (₹848.45), with an initial stop loss at ₹799, which can be shifted to ₹825 if the stock moves past ₹850 for a target of ₹900 with trailing stop-losses.

Follow-up: Though the strategy on BPCL moved on expected lines last Monday, subsequently the stock reversed the direction. Those who failed to book profits can hold the positions with a mentioned stop loss.

Note: The recommendations are based on technical analysis and F&O positions. There is a risk of loss in trading.

Published on June 11, 2022
  1. Comments will be moderated by The Hindu editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like

Recommended for you